Sunday, 27 April 2025

Myeloperoxidase: Cardiac Biomarker

 

                                                                           Neutrophil





Discovery Of Myeloperoxidase, 1941

Myeloperoxidase (MPO) was first isolated and purified by Kjell Agner in 1941 from green purulent fluid from patients with tuberculous empyema. 
Agner's work revealed that MPO was an enzyme structurally different from other proteins known at the time. 
He later investigated its ability to inactivate bacterial toxins. 
History Of Myeloperoxidase







Elevated Levels Of Myeloperoxidase Are Seen In 





Cardiac Biomarkers




Myeloperoxidase: Cardiac Biomarker 

Identifies Patients At Increased Risk Of Cardiovascular Events


Snapshot 

































No comments:

Post a Comment